Partnering

Partnerships are a central part of our corporate strategy and thus part of our innovation success. Around 50 percent of our pipeline projects are based on collaborations with external partners - currently more than 150 around the world. We are combining our innovative power to develop innovative therapies with breakthrough potential in our focus areas and beyond. As part of our research work, our partners also support us in accelerating processes so that effective therapies can be made available to patients more quickly.